Поисковый запрос: (<.>S=АРГАТРОБАН<.>) |
Общее количество найденных документов : 26
Показаны документы с 1 по 20
|
|
1.
| Effects of critical illness and organ failure on therapeutic argatroban dosage requirements in patients with suspected or confirmed heparin-induced thrombocytopenia // Ann. Pharmacother., 2009. Vol. 43, N 1.-С.19-27
|
2.
| Ansara Alexander J. Weight-based argatroban dosing nomogram for treatment of heparin-induced thrombocytopenia // Ann. Pharmacother., 2009. Vol. 43, N 1.-С.9-18, 114-117
|
3.
| Dager William E. Considerations for drug dosing post coronary artery bypass graft surgery // Ann. Pharmacother., 2008. Vol. 42, N 3.-С.421-424
|
4.
| Balasa Vinod V. New anticoagulants: A pediatric perspective // Pediat. Blood and Cancer, 2005. Vol. 45, N 6.-С.741-752
|
5.
| Prolonged half-life of Argatroban in patients with renal dysfunction and antiphospholipid antibody syndrome being treated for heparin-induced thrombocytopenia // Amer. J. Hematol., 2008. Vol. 83, N 3.-С.245-246
|
6.
| Ansara Alexander J. Weight-based argatroban dosing nomogram for treatment of heparin-induced thrombocytopenia // Ann. Pharmacother., 2009. Vol. 43, N 1.-С.9-18, 114-117
|
7.
| Reduced argatroban doses after coronary artery bypass graft surgery // Ann. Pharmacother., 2008. Vol. 42, N 3.-С.309-316
|
8.
| Prevention of platelet-rich arterial thrombosis by selective thrombin inhibition // Circulation, 1990. Vol. 81, N 1.-С.219-225
|
9.
| Combined administration of aspirin and a specific thrombin inhibitor in man // Circulation, 1991. Vol. 83, N 5.-С.1510-1518
|
10.
| Samama C.M. Coagulation intravasculaire disseminee (CIVD) Nouvelles modalites de traitement // J. eur. urgences., 1992. Vol. 5, N 4.-С.213-217
|
11.
| Comparison of bivalirudin and argatroban for the management of heparin-induced thrombocytopenia // Pharmacotherapy, 2010. Vol. 30, N 12.-С.1229-1238
|
12.
| Argatroban therapy in pediatric patients requiring nonheparin anticoagulation. An open-label, safety, efficacy, and pharmacokinetic study // Pediat. Blood and Cancer, 2011. Vol. 56, N 7.-С.1103-1109
|
13.
| Acceleration of reperfusion by combination of rt-PA and a selective thrombin inhibitor, Argatroban // Circulation, 1989. Vol. 80, N 4 Suppl..-С.II-217
|
14.
| Study of the pharmacological effect of the bile salt, sodium scymnol sulfate, from Rhizoprionodon acutus II: Prophylactic effect of scymnol on lesion development in a rat peripheral arterial occlusion model // Biol. and Pharm. Bull., 1998. Vol. 21, N 3.-С.240-244
|
15.
| Clinical laboratory monitoring of a synthetic antithrombin agent, argatroban, using HPLC and functional methods // Fibrinolysis and Proteolysis, 1998. Vol. 12, Suppl. n1.-С.78
|
16.
| Hantgan Roy R. No effect of clot age or thrombolysis on agratroban's inhibition of thrombin // Blood, 1998. Vol. 92, N 6.-С.2064-2074
|
17.
| Recanalization of acute occlusion after percutaneous transluminal coronary angioplasty (PTCA) using a synthetic thrombin inhibitor, argatroban // Fibrinolysis, 1994. Vol. 8, Suppl. n 1.-С.74
|
18.
| Effect of Argatroban on the formation of artificial thrombus on dogs // Int. J. Tissue React., 1995. Vol. 17, N 3.-С.109-116
|
19.
| Berry C.N. Argatroban enables streptokinase-induced thrombolysis in rabbit arterial thrombosis // Fibrinolysis, 1996. Vol. 10, Suppl. n 3.-С.57
|
20.
| Kondo L.Midori Argatroban for prevention and treatment of thromboembolism in heparin-induced thrombocytopenia // Ann. Pharmacother., 2001. Vol. 35, N 4.-С.440-451
|
|
|
|
Главная
Назад
"Электронные каталоги и базы данных библиотек СО РАН"